Abstract
This ESMO CPG provides key recommendations and algorithms for managing DLBCL, FL, HL, MCL, MZL, PCNSL and PTCL. •It covers epidemiology, diagnosis, staging, risk assessment, treatment of primary and refractory disease and follow-up. •Treatment algorithms for each lymphoma type are provided. •The author group encompasses a multidisciplinary group of experts from different institutions and countries in Europe. •Recommendations are based on available scientific data and the authors’ collective expert opinion.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 1263-1284 |
| Numero di pagine | 22 |
| Rivista | Annals of Oncology |
| Volume | 36 |
| Numero di pubblicazione | 11 |
| DOI | |
| Stato di pubblicazione | Pubblicato - nov 2025 |
Fingerprint
Entra nei temi di ricerca di 'Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver